About

Brendan O'Malley, J.D., Ph.D., joined Abeona in 2019 as Chief IP Counsel, bringing significant technical and legal expertise to the team. Prior to joining Abeona, he was a partner at the New York patent-litigation firm Fitzpatrick, Cella, Harper & Scinto, where he began his career as a summer associate in 2006, and then at Venable LLP, which merged with Fitzpatrick in 2018. He litigated a wide variety of biopharmaceutical patent cases in the U.S. District Courts, at the Federal Circuit and before the U.S. Patent and Trademark Office, negotiated numerous settlement and license agreements, and provided patent opinions in connection with M&A due diligence in the biotech space.

While attending law school, Dr. O'Malley served as a judicial intern to Judge William H. Pauley in the U.S. District Court for the Southern District of New York. Before law school he earned his Ph.D. at Tufts, studying the role of protein-protein interactions in hepatitis virus assembly.

Roles

Abeona Therapeutics Inc.
Chief Legal Officer · Current role
September 2021–present
Abeona Therapeutics Inc.
Chief Legal Officer
2021 - present
Abeona Therapeutics Inc.
Chief IP Counsel
2019 - 2021
Venable LLP (merged with Fitzpatrick, Cella, Harper & Scinto in 2018)
Partner
2018 - 2019
Fitzpatrick, Cella, Harper & Scinto
Partner (joined as summer associate in 2006)
2006 - 2018

Fixed Compensation

FY 2025
Salary
$456,435
ComponentAnnual base salary earned in FY2025
Bonus
$150,000
ComponentCash retention bonus paid June 23, 2025 to offset a 2022 equity shortfall versus recommended market grant
All other compensation
$14,000
ComponentEmployer matching contributions to the 401(k) Defined Contribution Plan
Total compensation
$1,383,926

Performance Compensation

Data from FY 2025

Cash incentive

Non-equity incentive plan compensation
$163,491
Target Opportunity
PlanTarget-based cash incentive bonus earned with respect to FY2025

Stock awards

Stock awards
$600,000
FormRestricted stock awards, aggregate grant-date fair value computed in accordance with ASC 718

Also at Abeona Therapeutics Inc.

Related

See how VectorShift works for your firm

Request Demo